Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong

Vaccine

Volumn 25, Issue 39-40, 2007, Pages 6837-6841

  Ho, Pak Leung ^a   Chiu, Susan S ^a,b   Chow, Frankie K H ^a   Mak, Gannon C ^a   Lau, Yu Lung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Children; Pneumococcal disease; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL MENINGITIS; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; HONG KONG; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFECTION PREVENTION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPTICEMIA; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VACCINATION;

BACTEREMIA; CHILD, PRESCHOOL; HONG KONG; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTERNATIONAL CLASSIFICATION OF DISEASES; MENINGITIS, PNEUMOCOCCAL; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 34548550428     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.039     Document Type: Article

References (17)

1. Black S.B., Shinefield H.R., Ling S., Hansen J., Fireman B., Spring D., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 21 (2002) 810-815
2. Kyaw M.H., Lynfield R., Schaffner W., Craig A.S., Hadler J., Reingold A., et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 April (2006) 1455-1463
3. Ho P.L., Lam K.F., Chow F.K., Lau Y.L., Wong S.S., Cheng S.L., et al. Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children. Vaccine 22 September (2004) 3334-3339
4. Ho P.L., Chiu S.S., Cheung C.H., Lee R., Tsai T.F., and Lau Y.L. Invasive pneumococcal disease burden in Hong Kong children. Pediatr Infect Dis J 25 (2006) 454-455
5. Chiu S.S., Lau Y.L., Chan K.H., Wong W.H., and Peiris J.S. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347 December (2002) 2097-2103
6. Guevara R.E., Butler J.C., Marston B.J., Plouffe J.F., File Jr. T.M., and Breiman R.F. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 149 February (1999) 282-289
7. Cherian T., Mulholland E.K., Carlin J.B., Ostensen H., Amin R., de Campo M., et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 83 (2005) 353-359
8. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 6-10-2000;49:1-35.
9. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19 (2000) 187-195
10. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 March (2005) 1139-1146
11. Andresen D.N., and Collignon P.J. Invasive pneumococcal disease in the Australian Capital Territory and Queanbeyan region: do high infant rates reflect more disease or better detection?. J Paediatr Child Health 40 (2004) 184-188
12. McIntosh E.D. How many episodes of hospital care might be prevented by widespread uptake of pneumococcal conjugate vaccine?. Arch Dis Child 88 (2003) 859-861
13. D'Ancona F., Salmaso S., Barale A., Boccia D., Lopalco P.L., Rizzo C., et al. Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy. Vaccine 23 March (2005) 2494-2500
14. Ho P.L., Que T.L., Ng T.K., Chiu S.S., Yung R.W., and Tsang K.W. Clinical outcomes of bacteremic pneumococcal infections in an area with high resistance. Eur J Clin Microbiol Infect Dis 25 (2006) 323-327
15. Madhi S.A., Kuwanda L., Cutland C., and Klugman K.P. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 40 May (2005) 1511-1518
16. Madhi S.A., and Klugman K.P. World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines. Vaccine 25 March (2007) 2413-2419
17. Grijalva C.G., Nuorti J.P., Arbogast P.G., Martin S.W., Edwards K.M., and Griffin M.R. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369 April (2007) 1179-1186